Top L.A. Facial Plastic Surgeon, Dr. Jacob Sedgh, is One of the First Exclusive Providers to Offer the New FDA-Approved Daxxify™, an Alternative to Botox Treatment
Daxxify ™ (daxibotulinumtoxinA-lanm) is a new injectable wrinkle treatment that is FDA-approved to improve the appearance of moderate to severe glabellar lines, the frown lines or "elevens" between the eyebrows.
WEST HOLLYWOOD, Calif., June 1, 2023 /PRNewswire-PRWeb/ -- Dr. Jacob Sedgh is pleased to announce that DAXXIFY™, the only long-lasting, peptide-powered wrinkle injection treatment, is now available at his practice. Well-respected Los Angeles plastic surgeon Dr. Sedgh is one of just a few select providers to currently offer this innovative treatment to patients. Daxxify is a new injectable wrinkle treatment that's FDA-approved to improve the appearance of moderate to severe glabellar lines, frown lines or "elevens" between the eyebrows. It can be used off-label to treat other wrinkles, like forehead furrows, crow's feet and bunny lines, as well as platysmal bands in the neck and dimpling of the chin. As with other toxins, it can also be injected into the masseter muscles to soften a square, bulky jaw while reducing the clenching and grinding associated with TMJ. Like Botox, Dysport, and Xeomin, Daxxify (a.k.a. Daxi) works by temporarily blocking the release of the neurotransmitter that causes muscle movement. This smooths the "dynamic wrinkles" and prevents new expression lines from forming. What's unique about Daxxify is its longevity with clinical studies showing an improvement in frown lines for six to nine months (compared to the standard three to five-month result offered by previously approved neuromodulators, like Botox). Daxxify is safe and effective for most patients and is unique because it is the only formulation that uses a novel peptide as a stabilizer and does not contain human or animal byproducts. With 20 years of research behind it and the largest phase-3 clinical trial program done on frown line treatment, patients can feel confident that this treatment is safe on most skin types.
"Daxxify is one of the safest, newest and most effective treatments on the market for wrinkles and fine lines for many patients, and with fewer treatments necessary for results compared to Botox and other similar products," says Dr. Jacob Sedgh.
More about Dr. Jacob Sedgh:
With the benefit of two decades of medical training and practical experience at top medical institutions in the United States, Dr. Jacob Sedgh combines mastery of medical knowledge and surgical skills with the attention and perfection of a sculptor, delivering highly-personalized patient care. Dr. Sedgh attended the University of California, San Diego School of Medicine, receiving honors and recognition signifying his achievements as a top-tier graduate and completed a surgical internship at the University of California, San Francisco. He concluded his residency in otolaryngology and head and neck surgery at the prestigious University of Pittsburgh Medical Center. Dr. Sedgh then completed a fellowship at Penn State Hershey Medical Center focusing on facial cosmetic and reconstructive surgery. Whether it is the finesse of rhinoplasty to achieve a refined nose or the extensive reconstructive work on cancer patients to optimally restore form and function, board-certified facial plastic surgeon Dr. Jacob Sedgh creates beautiful, natural results at his clinic located at 9201 Sunset Blvd, Suite 404 in West Hollywood, CA. For more information or to schedule a consultation, please call 310-504-7604 or visit http://www.sedghplasticsurgery.com.
Dr Jacob Sedgh, Jacob Sedgh, MD, 310-504-7604, firstname.lastname@example.org
SOURCE Jacob Sedgh, MD
Upcoming Life Sciences Events
- September 2023
- Barcelona: BioSpain 2023
- October 2023
- New York City: BioFuture
Latest company news
BioCity Signs Collaboration Agreement with AstraZeneca on BC3402, a monoclonal antibody targeting anti-TIM-3, in Combination with IMFINZI (durvalumab) for the Treatment of Advanced Hepatocellular Carcinoma in China